Broad-Based Companies: Company Announcements
ICx Technologies formed ICx Cryogenics to exclusively distribute Rico Cryogenic & Vacuum Systems’ products.
PerkinElmer launched the EcoAnalytix Initiative, a series of application-oriented platforms for food safety, water quality and biofuels development, and announced the establishment of four EcoAnalytix global application development centers in Shelton, Connecticut; Seer Green, England; Shanghai, China; and Mumbai, India.
In October, Bruker BioSciences and Bruker BioSpin officially opened a new application, demonstration and customer training center in Beijing, China.
Symyx Technologies elected Dr. David Hill, president and CEO of Sun Chemical, to its Board. Edwin F. Gambrell retired from the Board in October.
Thermo Fisher Scientific broke ground on a $17 million, 100,000 square foot clinical trial services facility in Ahmadabad, India. It is expected to open in spring 2008.
Becton, Dickinson and Company elected Cathy E. Minehan, former president and CEO of the Federal Reserve Bank of Boston, to its Board in November.
SciMercor, a laboratory equipment sourcing and shipping services company, opened in November in Seattle, Washington.
In November, photonics supplier Jenoptik Group announced a reorganization effective January 2008 under which it will operate in three segments (Lasers and Optical Systems, Metrology, Defense and Civil Systems) with five divisions.
In November, Applera named George F. Adam, Jr. to its Board, expanding the Board to 11 members. He is chairman of Recondo Technology, a healthcare software development company.
Whatman named Dr. Stephan Fleck as vice president of Technical Operations. He comes to the company from Bayer Healthcare.
In November, Agilent announced it will spend $100 million over three years to build a 300,000 sq. ft. innovation center in Malaysia. Agilent opened two facilities for R&D and manufacturing in 2003 in Penang.
Spectris Board member and Business Group Director Stephen Harris will resign from the company effective January 31, 2008.
Oxford Instruments revenues for the half year ended September 30 rose 9% (15% in constant currency including 13% organic growth) to £78.3 million ($156.6 million) (see IBO 11/30/07). Operating profit was flat at £2.0 million ($4.0 million). Analytical sales rose 14.5% to £49.6 million ($99.2 million) as slowing Industrial Analysis sales for RoHS applications were offset by strong positive material identification sales. X-Ray Technology sales also slowed due to reduced RoHS demand, but NanoAnalysis and Plasma Technology sales were strong. Superconductivity sales were flat at £28.7 million ($57.4 million) as shipments of HyperSense equipment doubled to 10.